Supriya Lifescience Balance Sheet Health
Financial Health criteria checks 6/6
Supriya Lifescience has a total shareholder equity of ₹7.5B and total debt of ₹57.7M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₹8.4B and ₹898.6M respectively. Supriya Lifescience's EBIT is ₹1.6B making its interest coverage ratio -21.6. It has cash and short-term investments of ₹1.2B.
Key information
0.8%
Debt to equity ratio
₹57.71m
Debt
| Interest coverage ratio | -21.6x |
| Cash | ₹1.16b |
| Equity | ₹7.53b |
| Total liabilities | ₹898.57m |
| Total assets | ₹8.43b |
Recent financial health updates
No updates
Recent updates
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings
May 10
Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E
Feb 09Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit
May 28Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower
May 07Financial Position Analysis
Short Term Liabilities: SUPRIYA's short term assets (₹4.1B) exceed its short term liabilities (₹655.9M).
Long Term Liabilities: SUPRIYA's short term assets (₹4.1B) exceed its long term liabilities (₹242.7M).
Debt to Equity History and Analysis
Debt Level: SUPRIYA has more cash than its total debt.
Reducing Debt: SUPRIYA's debt to equity ratio has reduced from 120.9% to 0.8% over the past 5 years.
Debt Coverage: SUPRIYA's debt is well covered by operating cash flow (2291.1%).
Interest Coverage: SUPRIYA earns more interest than it pays, so coverage of interest payments is not a concern.